Nosaka Nobuyuki, Muguruma Takashi, Fujiwara Takeo, Enomoto Yuki, Toida Chiaki, Morishima Tsuneo
Division of Acute and Critical Care Department of Critical Care and Anesthesia National Medical Center for Children and Mothers Tokyo Japan.
Department of Pediatrics Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan.
Acute Med Surg. 2014 Sep 17;2(2):92-97. doi: 10.1002/ams2.76. eCollection 2015 Apr.
To investigate the necessary indicators to diagnose pediatric myocarditis and choose appropriate candidates for extracorporeal membrane oxygenation therapy.
We retrospectively reviewed the medical records of children aged <16 years of age who were diagnosed with myocarditis and admitted to the pediatric intensive care unit in a Japanese children's hospital from 2002 to 2013. We collected demographic data and symptoms and signs during the entire clinical course, investigated the survival and neurological outcomes, and identified the predictors of death.
Twenty-nine patients (median age, 5 years) met the inclusion criteria. Fever and gastrointestinal symptoms occurred in approximately 80% of the patients as initial symptoms and central nervous system symptoms were the most frequent symptom on emergency presentation (41%). Extracorporeal membrane oxygenation was administered to 16 patients; of these, five died. Of the 24 surviving patients, 23 achieved favorable neurological outcomes. Four of eight patients died following cardiopulmonary resuscitation-triggered extracorporeal membrane oxygenation, and one of eight died following elective extracorporeal membrane oxygenation. Multivariate analysis using stepwise logistic regression analysis revealed creatinine level as an independent predictor of death.
It is important to consider myocarditis when evaluating children with gastrointestinal or central nervous system symptoms. The elective introduction of extracorporeal membrane oxygenation before the completion of end-organ dysfunction has a positive effect on outcomes in pediatric myocarditis cases. Transfer to an institution that can initiate extracorporeal membrane oxygenation support should be promptly considered when managing pediatric myocarditis.
研究诊断小儿心肌炎的必要指标,并为体外膜肺氧合治疗选择合适的患者。
我们回顾性分析了2002年至2013年期间在日本一家儿童医院被诊断为心肌炎并入住儿科重症监护病房的16岁以下儿童的病历。我们收集了整个临床过程中的人口统计学数据、症状和体征,调查了生存情况和神经学结局,并确定了死亡的预测因素。
29例患者(中位年龄5岁)符合纳入标准。约80%的患者最初症状为发热和胃肠道症状,中枢神经系统症状是急诊时最常见的症状(41%)。16例患者接受了体外膜肺氧合治疗;其中5例死亡。在24例存活患者中,23例获得了良好的神经学结局。8例心肺复苏后启动体外膜肺氧合治疗的患者中有4例死亡,8例择期体外膜肺氧合治疗的患者中有1例死亡。采用逐步逻辑回归分析的多变量分析显示肌酐水平是死亡的独立预测因素。
在评估有胃肠道或中枢神经系统症状的儿童时,考虑心肌炎很重要。在终末器官功能障碍出现之前择期引入体外膜肺氧合对小儿心肌炎病例的结局有积极影响。在处理小儿心肌炎时,应及时考虑转至能够启动体外膜肺氧合支持的机构。